Bavarian Nordic

Bavarian Nordic Secures EU Approval for IMVANEX in Children

COPENHAGEN, Denmark, August 7, 2026 Bavarian Nordic announced that the European Commission (EC) has approved a Type II variation...

By cGxPwire Editor
August 7, 2026

Bio-Pharma

Bavarian Nordic Seeks Brazil Approval for Chikungunya Vaccine

COPENHAGEN, Denmark, July 13, 2026 Bavarian Nordic announced that its Brazilian partner Eurofarma has submitted a marketing authorization application...

By cGxPwire Editor
July 15, 2026

Pharma

Bavarian Nordic Wins Swiss Approval for Chikungunya Vaccine

COPENHAGEN, Denmark, April 16, 2026 Bavarian Nordic A/S has announced that Swissmedic, the Swiss Agency for Therapeutic Products, has...

By cGxPwire Editor
April 16, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Bavarian Nordic Secures EU Approval for IMVANEX in Children

Bavarian Nordic Seeks Brazil Approval for Chikungunya Vaccine

Bavarian Nordic Wins Swiss Approval for Chikungunya Vaccine